Treatment of Bipolar Postpartum Depression
common.study.values.description
“Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression”
The investigators will conduct a 6-week, randomized, double-blind, placebo-controlled trial of celecoxib as an add-on treatment to the mood stabilizer among women with bipolar I or II postpartum depression. Women who are taking a mood stabilizer for treatment of bipolar disorder in the postpartum treatment will receive either a placebo or celecoxib add-on treatment. Patients will be monitored regularly to assess psychiatric symptoms and side effects. The investigators aim to evaluate the potential antidepressant effect of celecoxib in bipolar postpartum depression.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-yes
Drug - Celecoxib
Adjunct celecoxib
Drug - Placebo
Adjunct placebo
participant.views.study.view.additional
participant.views.study.view.scientific-title
Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression: a Randomized, Double-blind, Placebo-controlled Trial
common.study.values.clinical-trial-id
NCT02726659
participant.views.study.view.id
9b6VNb
